Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test
Clinical narrative: The Paxlovid cured symptoms by Day6; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (The Paxlovid cured symptoms by Day6) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Patient's past drug allergy was reported as none.  Concurrent medical conditions included Asthma.    On 10-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (The Paxlovid cured symptoms by Day6). The patient was treated with NIRMATRELVIR, RITONAVIR (PAXLOVID) from 11-May-2022 to 15-May-2022 for COVID-19 treatment, at an unspecified dose and frequency. In May 2022, COVID-19 (The Paxlovid cured symptoms by Day6) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 20-May-2022, SARS-CoV-2 test: positive (Positive) Positive. On an unknown date, SARS-CoV-2 test: positive (Positive) Positive.        The patient was not taking any other medications or products within 2 weeks of starting COVID-19 treatment with Paxlovid. No concomitant medications were reported. company comment This spontaneous case reported by a 40 year old female patient, with relevant medical history of Asthma, who experienced the unexpected, non-serious AESI of covid 19 Infection on an unknown date, about 6 months after receiving the 3 dose of Modena mRNA1273 vaccine in the covid 19 vaccination series. Details of primary doses was not provided. On an unknown date SARS-CoV-2 test was positive. the patient was started on Paxlovid for Covid 19 Infection for 6 days. The outcome of the event was unknown. It was reported that the Patient again tested positive for SARS-CoV-2 test about 5 days after stopping Paxlovid with return of symptoms and having new symptoms including, upset stomach, head and chest congestion, sore throat and fatigue. Ongoing Covid 19 pandemia could be considered as confounder to the event. The benefit-risk relationship of mRNA-1273 Vaccine is not affected by this report. Event seriousness assessed as per medical judgement.; Sender's Comments: This spontaneous case reported by a 40 year old female patient, with relevant medical history of Asthma, who experienced the unexpected, non-serious AESI of covid 19 Infection on an unknown date, about 6 months after receiving the 3 dose of Modena mRNA1273 vaccine in the covid 19 vaccination series. Details of primary doses was not provided. On an unknown date SARS-CoV-2 test was positive. the patient was started on Paxlovid for Covid 19 Infection for 6 days. The outcome of the event was unknown. It was reported that the Patient again tested positive for SARS-CoV-2 test about 5 days after stopping Paxlovid with return of symptoms and having new symptoms including, upset stomach, head and chest congestion, sore throat and fatigue. Ongoing Covid 19 pandemia could be considered as confounder to the event. The benefit-risk relationship of mRNA-1273 Vaccine is not affected by this report. Event seriousness assessed as per medical judgement.